Taking 4&5 into account, we made the following observations in the lung (6) and cardiovascular system (7):
1.The biological impact factors of all mechanisms affected by smoke are reduced by >95% in e-vapor exposed animals (slide 11).
2.This is coherent with cell and tissue changes (slide 10), and reflects the differences in molecular inflammation markers (slide 10).
1.Atherosclerotic plaque growth rate was reduced by >80% (slide 13).
2.Gene exp. changes in heart and aorta reduced by >95% (slide 14).
3.Arterial stiffness stat signif reduced, but by ~20%: This is the differential between smoke and nicotine effects (slide 15).
A. The difference in toxicant emissions between the tested e-vapors and smoke.
B. The vascular effect of nicotine.
1.Previous e-vapor studies: see ncbi.nlm.nih.gov/pubmed/30849254; ncbi.nlm.nih.gov/pubmed/30835057.
2.Previous studies with #heatnotburn platforms: see ncbi.nlm.nih.gov/pubmed/30763686; ncbi.nlm.nih.gov/pubmed/27225756; and related papers.